Wells Fargo’s Molecular Templates, Inc. MTEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36
| Closed | -$81 | – | 7756 |
|
|
2024
Q1 | $81 | Buy |
36
+1
| +3% | +$3 | ﹤0.01% | 6715 |
|
|
2023
Q4 | $131 | Buy |
35
+2
| +6% | +$10 | ﹤0.01% | 6704 |
|
|
2023
Q3 | $209 | Buy |
33
+11
| +50% | +$87 | ﹤0.01% | 6573 |
|
|
2023
Q2 | $158 | Buy |
22
+1
| +5% | +$7 | ﹤0.01% | 6765 |
|
|
2023
Q1 | $120 | Hold |
21
| – | – | ﹤0.01% | 6898 |
|
|
2022
Q4 | $102 | Buy |
21
+1
| +5% | +$8 | ﹤0.01% | 6787 |
|
|
2022
Q3 | $0 | Buy |
20
+1
| +5% | +$13 | ﹤0.01% | 7711 |
|
|
2022
Q2 | $0 | Sell |
19
-188
| -91% | -$4.4K | ﹤0.01% | 7811 |
|
|
2022
Q1 | $11K | Sell |
207
-876
| -81% | -$38.7K | ﹤0.01% | 6247 |
|
|
2021
Q4 | $63K | Buy |
1,083
+1,053
| +3,510% | +$78.9K | ﹤0.01% | 5860 |
|
|
2021
Q3 | $3K | Sell |
30
-333
| -92% | -$34.3K | ﹤0.01% | 6526 |
|
|
2021
Q2 | $43K | Sell |
363
-553
| -60% | -$72.4K | ﹤0.01% | 5624 |
|
|
2021
Q1 | $174K | Sell |
916
-3,862
| -81% | -$677K | ﹤0.01% | 5224 |
|
|
2020
Q4 | $673K | Sell |
4,778
-341
| -7% | -$50.4K | ﹤0.01% | 4306 |
|
|
2020
Q3 | $838K | Sell |
5,119
-1,068
| -17% | -$190K | ﹤0.01% | 3990 |
|
|
2020
Q2 | $1.28M | Buy |
6,187
+1,616
| +35% | +$375K | ﹤0.01% | 3619 |
|
|
2020
Q1 | $911K | Buy |
4,571
+1,187
| +35% | +$260K | ﹤0.01% | 3599 |
|
|
2019
Q4 | $710K | Sell |
3,384
-2,936
| -46% | -$422K | ﹤0.01% | 4100 |
|
|
2019
Q3 | $625K | Buy |
6,320
+1,095
| +21% | +$102K | ﹤0.01% | 4216 |
|
|
2019
Q2 | $654K | Buy |
5,225
+4,431
| +558% | +$481K | ﹤0.01% | 4194 |
|
|
2019
Q1 | $69K | Sell |
794
-296
| -27% | -$21.7K | ﹤0.01% | 5252 |
|
|
2018
Q4 | $66K | Buy |
1,090
+131
| +14% | +$9.14K | ﹤0.01% | 5439 |
|
|
2018
Q3 | $77K | Buy |
959
+272
| +40% | +$20.9K | ﹤0.01% | 5457 |
|
|
2018
Q2 | $54K | Buy |
687
+31
| +5% | +$3.51K | ﹤0.01% | 5573 |
|
|
2018
Q1 | $79K | Sell |
656
-13
| -2% | -$1.96K | ﹤0.01% | 5409 |
|
|
2017
Q4 | $101K | Buy |
669
+633
| +1,758% | +$79.5K | ﹤0.01% | 5307 |
|
|
2017
Q3 | $4K | Buy |
36
+24
| +200% | +$2.07K | ﹤0.01% | 6086 |
|
|
2017
Q2 | $1K | Buy |
+12
| New | +$944 | ﹤0.01% | 6157 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6577 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6507 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6404 |
|
|
2016
Q2 | – | Sell |
-162
| Closed | -$11.6K | – | 6405 |
|
|
2016
Q1 | $12K | Buy |
162
+12
| +8% | +$708 | ﹤0.01% | 5646 |
|
|
2015
Q4 | $11K | Sell |
150
-449
| -75% | -$221K | ﹤0.01% | 5721 |
|
|
2015
Q3 | $402K | Sell |
599
-12
| -2% | -$8.54K | ﹤0.01% | 4084 |
|
|
2015
Q2 | $407K | Buy |
611
+142
| +30% | +$93.8K | ﹤0.01% | 4213 |
|
|
2015
Q1 | $314K | Buy |
469
+30
| +7% | +$19.8K | ﹤0.01% | 4203 |
|
|
2014
Q4 | $231K | Buy |
439
+101
| +30% | +$50.5K | ﹤0.01% | 4347 |
|
|
2014
Q3 | $201K | Sell |
338
-26
| -7% | -$18K | ﹤0.01% | 4355 |
|
|
2014
Q2 | $238K | Buy |
364
+22
| +6% | +$14.6K | ﹤0.01% | 4296 |
|
|
2014
Q1 | $268K | Buy |
342
+336
| +5,600% | +$273K | ﹤0.01% | 4201 |
|
|
2013
Q4 | $4K | Sell |
6
-3
| -33% | -$2.26K | ﹤0.01% | 5430 |
|
|
2013
Q3 | $7K | Buy |
9
+6
| +200% | +$4.93K | ﹤0.01% | 5211 |
|
|
2013
Q2 | $3K | Buy |
+3
| New | +$2.54K | ﹤0.01% | 5333 |
|
Other funds holding MTEM
BG
SCM
BI
CC
I
HF
Wells Fargo's MTEM Position: Q2 2024 in Review
Wells Fargo sold out of Molecular Templates, Inc. (MTEM) in Q2 2024, closing a stake of 36 shares — an estimated $81 sold.
Wells Fargo first reported a position in MTEM in Q2 2013 and held it in 40 quarters. The position peaked at $1.28M in Q2 2020. 28 funds tracked by Wall St. Rank hold MTEM as of Q2 2024.
- Wells Fargo reported no remaining Molecular Templates, Inc. position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 36 Molecular Templates, Inc. shares in Q2 2024, an estimated $81.
- Wells Fargo first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 40 quarters.
- Wells Fargo's Molecular Templates, Inc. position peaked at $1.28M in Q2 2020.
- 28 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.